elotuzumab

Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
AbbVie
Bristol-Myers Squibb
FDA
elotuzumab
Multiple Myeloma
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Bristol, AbbVie drug extends multiple myeloma remission-study
Yahoo/Reuters
Thu, 05/14/15 - 09:56 am
Bristol-Myers Squibb
AbbVie
Multiple Myeloma
elotuzumab
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
The Fly on the Wall
Mon, 05/19/14 - 09:17 am
Bristol-Myers Squibb
AbbVie
elotuzumab
Multiple Myeloma
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab